SMTL ID : 5k75.1 (3 other biounits)

IRAK4 in complex with Compound 1

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.03 Å

Oligo State

monomer

Ligands

1 x 6QX: ~{N}1-(7,8-dihydro-6~{H}-cyclopenta[2,3]thieno[2,4-~{c}]pyrimidin-1-yl)-~{N}4,~{N}4-dimethyl-cyclohexane-1,4-diamine(Non-covalent)

6QX.1: 12 residues within 4Å: Chain A: M.33, G.34, E.35, V.41, A.52, Y.103, V.104, Y.105, M.106, S.110, D.113, L.159 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:Y.103, A:L.159, A:L.159 Hydrogen bonds: A:M.106 Water bridges: A:S.110 Salt bridges: A:D.113

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Scott, J.S. et al., Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma. J. Med. Chem. (2017)

Release Date

2017-12-06

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence